ROYCE & ASSOCIATES LP - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 115 filers reported holding ARATANA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$56,000
+3.7%
9,2000.0%0.00%
Q3 2018$54,0009,2000.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders